Ali S.M., Harvey H.A., Lipton Allan. Metastatic Breast Cancer: Overview of Treatment. Clinical Orthopaedics and Related Research. 2003;415:S132-S137. doi:10.1097/01.blo.0000092981.12414.7b.
Abstract
Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.
Last Updated on September 30, 2026
🔗 Knowledge Graph & Clinical Correlates
OrthopaedicsOne Living Semantic Network🩺 Clinical Conditions & Indications
- Wigns There are three categories of diagnostic data collected during the physical examination (sign, symptom, and that in between)...
- Why have a privacy policy for my office Original Clinical Contribution: Authored for the OrthopaedicsOne General Orthopaedics Specialty Section. Preserved, digitized, and updated to modern evidence-based...
- Why have a practice website Original Clinical Contribution: Authored for the OrthopaedicsOne General Orthopaedics Specialty Section. Preserved, digitized, and updated to modern evidence-based...
- Who should undergo biopsy of a bone lesion Patient selection for a biopsy is important: It is intended to confirm the radiologic diagnosis in patients with...
💼 Practice Management & Professional Operations
- Winthrop M. Phelps History of Orthopaedics
- Willis Cohoon Campbell History of Orthopaedics
- William Waugh History of Orthopaedics
- William Ward Plummer History of Orthopaedics
- William Thomas Gordon Pugh History of Orthopaedics
- William Stewart Halsted History of Orthopaedics
- William Stevenson Baer History of Orthopaedics
- William Morant Baker History of Orthopaedics